Overall Survival Data Confirm Benefit of Pembro in TNBC ...Middle East

Medscape - News
Neoadjuvant plus adjuvant immune therapy combined with chemotherapy reduced death by 34% in the KEYNOTE-522 trial. Medscape Medical News

Hence then, the article about overall survival data confirm benefit of pembro in tnbc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Overall Survival Data Confirm Benefit of Pembro in TNBC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News